Drug Search Results
More Filters [+]

Dexpramipexole

Alternative Names: dexpramipexole, kns-760704, kns760704, kns 760704
Latest Update: 2025-01-08
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Knopp Biosciences
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Dexpramipexole

Countries in Clinic: Argentina, Austria, Brazil, Bulgaria, Canada, Colombia, Croatia, Czech Republic, France, Georgia, Germany, Hungary, Italy, Korea, Lithuania, Macedonia, Mexico, Poland, Puerto Rico, Romania, Serbia, South Africa, South Korea, Spain, Taiwan, Ukraine, United Kingdom, United States

Active Clinical Trial Count: 12

Highest Development Phases

Phase 3: Asthma|Pulmonary Eosinophilia

Phase 2: Chronic Obstructive Pulmonary Disease

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

EXHALE-5

P3

Enrolling by invitation

Pulmonary Eosinophilia|Asthma

2027-06-01

AR-DEX-22-04

P3

Unknown Status

Asthma

2027-02-20

jRCT2031240072

P3

Not yet recruiting

Asthma

2026-12-11

AR-DEX-22-01

P3

Unknown Status

Asthma

2026-07-27

Recent News Events